The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 2, 2010, Pages 207-212

  Sersté, Thomas ^a,b   Moreno, Christophe ^c   Francoz, Claire ^a   Razek, Walid Abdel ^a   Paugham, Catherine ^a   Belghitti, Jacques ^a   Valla, Dominique ^a   Moreau, Richard ^a   Durand, Francois ^a  

^a BEAUJON HOSPITAL   (France)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Cirrhosis; Hepatic hydrothorax; Liver transplantation; Outcome; Portal hypertension

Indexed keywords

FUROSEMIDE; SPIRONOLACTONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HYDROTHORAX; INTENSIVE CARE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; THORACOCENTESIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; HYDROTHORAX; INTENSIVE CARE; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARACENTESIS; PREOPERATIVE PERIOD; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 75749085849     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283311140     Document Type: Article

References (26)

1. Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49:193-203.
2. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997; 17:227-232.
3. Alberts WM, Salem AJ, Salomon DA, Boyce G. Hepatic hydrothorax. Cause and management. Arch Intern Med 1991; 151:2383-2388.
4. Zenda T, Miyamoto S, Murata S, Mabuchi H. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol 1998; 93:2288-2289.
5. Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther 2004; 20:271-279.
6. Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann inter Med 1996; 64:341-351.
7. Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003; 9:261-265.
8. Lebrec D, Vinel JP, Dupas JL. Management of portal hypertension: a french consensus. Gastroenterol Clin Biol 2004; 28:B5. (Pubitemid 38620699)
9. Cadranel JL, Jouannaud V, Duron JJ. Management of hepatic hydrothorax. Gastroenterol Clin Biol 2004; 28:B287-B300.
10. Consigny Y. Management of hydrothorax. Gastroenterol Clin Biol 2004; 28:B146-B155.
11. Konstantinos N, Lazaridis MD, Jeffrey W, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107:262-267.
12. Garcia N Jr, Mihas AA. Hepatic hydrothorax. Pathophysiology, diagnosis, and management. J Clin Gastroenterol 2004; 38:52-58.
13. Xiol X, Tremosa G, Castellote J, Gornals J, Lama C, Lopez C, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int 2005; 18:672-675.
14. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25:619-622.
15. Xiol X, Castellote J, Ballielas C, Ariza J, Gimenez Rocca A, Guardiola J, et al. Spontaneous bacterial empyema in cirrhotic patientsanalysis of eleven cases. Hepatology 1990; 11:365-370.
16. Assouad J, Le Pimpec Barthes F, Shaker W, Souleimas R, Riquet M. Recurrent pleural effusion complicating liver cirrhosis. Ann Thorac Surg 2003; 75:986-989.
17. Xiol X, Castellote J, Cortes-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracocenthesis in cirrhotic patients. Am J Med 2001; 111:67-69.
18. Castellote J, Xiol X, Corté s-Beut R, Tremosa G, Rodríguez E, Vázquez S. Complications of thoracocenthesis in cirrhotic patients with pleural effusion. Rev Esp Enferm Dig 2001; 93:571-575. (Pubitemid 33014617)
19. Runjon BA, Greenblatt M, Ming RHC. Hepatic hydrothorax is a relative contraindication to chest tube insertion. Am J Gastroenterol 1986; 81:566-567.
20. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt, long term result in 40 patients. Eur J Gastroenterol Hepatol 2001; 13:529-534.
21. Temes RT, Davis MS, Follis FM, Pett SB Jr, Wernly JA. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg 1997; 64:1468-1469.
22. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321:1632-1638.
23. Marujo WC, Takaoka F, Moura RM, Pandullo FL, Morrone AR, Linhares MM, et al. Early perioperative death associated with reexpansion pulmonary edema during liver transplantation. Liver Transpl 2005; 11:1439-1443.
24. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med 1999; 107:262-267.
25. De Wolf AM. Preoperative optimization of patients with liver disease. Cir Opin Anesthesiol 2005; 18:325-331.
26. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol 2002; 13:385-390.